Filing Details
- Accession Number:
- 0001773751-24-000014
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-16 16:47:56
- Reporting Period:
- 2024-02-14
- Accepted Time:
- 2024-02-16 16:47:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1773751 | Hims & Hers Health Inc. | HIMS | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1837817 | Soleil Boughton | 2269 Chestnut Street, #523 San Francisco CA 94123 | Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2024-02-14 | 17,109 | $2.43 | 171,454 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2024-02-14 | 17,109 | $10.00 | 154,345 | No | 4 | S | Direct | |
Class A Common Stock | Acquisiton | 2024-02-15 | 5,972 | $2.43 | 160,317 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2024-02-15 | 5,972 | $10.04 | 154,345 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Stock Option (right to buy) | Disposition | 2024-02-14 | 17,109 | $0.00 | 17,109 | $2.43 |
Class A Common Stock | Stock Option (right to buy) | Disposition | 2024-02-15 | 5,972 | $0.00 | 5,972 | $2.43 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
183,362 | 2030-05-12 | No | 4 | M | Direct | |
177,390 | 2030-05-12 | No | 4 | M | Direct |
Footnotes
- The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 8, 2023 by the Reporting Person.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $10.00 - $10.005. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $10.00 - $10.11. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- The option award vests over a four year period, with 1/48 of the shares subject to the stock option vesting when the Reporting Person completes each month of continuous Service beginning February 12, 2020. 100% of the shares subject to the option award are fully vested.